# A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects

> **NCT02575482** · PHASE1 · COMPLETED · sponsor: **Suven Life Sciences Limited** · enrollment: 64 (actual)

## Conditions studied

- Cognitive Disorders

## Interventions

- **DRUG:** SUVN-D4010
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02575482
- **Lead sponsor:** Suven Life Sciences Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-02
- **Final completion:** 2016-06
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2016-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02575482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02575482, "A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02575482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*